"In 2026, the U.S. healthcare sector faces transformative shifts driven by AI integration accelerating drug discovery and operational efficiencies, surging…
HighLife's innovative transcatheter mitral valve replacement system has secured CE Mark approval, enabling European commercialization for high-risk adult patients with…